Skip to main content
OpenTrials
Completed

NCT Number: NCT05155670

Hand Motor Rehabilitation Using a Wearable Robotic Device (WRL HX MCP)

The purpose of this pilot study is to assess the safety and usability of the WRL HX MCP medical device, a prototypal robotic system for metacarpophalangeal joint mobilization. WRL HX MCP was developed by the Wearable Robotics Laboratory of Scuola Superiore Sant'Anna in a project funded by and in collaboration with INAIL, to fulfil the needs of patients with post-traumatic hand stiffness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

INAIL - Centro di Riabilitazione Motoria di Volterra

Volterra, Pisa, 56048, Italy

About this study

This study aims to:

  • Test the safety and reliability of the WRL HX MCP device for assisting flexion and extension movement of the stiff metacarpophalangeal joint
  • Conduct a preliminary examination of the efficacy of the device in the treatment of joint stiffness to design a subsequent RCT
  • Evaluate the performance of the device in estimating the biomechanical parameters useful for the objective treatment outcome assessment.

Ten injured workers with post-traumatic and/or post-operative index finger MCP stiffness will be enrolled in a clinical trial consisting of one to four sessions of robotic therapy with WRL HX MCP at the INAIL Rehabilitation Center in Volterra.

Pilot testing of the experimental device will include the preliminary goniometric measure of passive and active MCP range of motion (ROM), the selection of the appropriate size of exoskeleton segments to fit user's anthropometry, the robotic assessment of ROM, force and torque trajectories of MCP joint, a program of robot-assisted passive and active MCF mobilization and a final clinical and robotic reassessment of joint ROM. The session will last about 1 hour and all exercises will be administered by a trained physical therapist supported by two members of the engineering team; pain level will be assessed at baseline and after each mobilization sequence; patient feedback will be recorded about the usability of the device in term of comfort, wearability, user safety, and overall satisfaction.

For Aim 1, the Safety and Reliability of the device will be evaluated in terms of the number of adverse events and malfunctions occurring during the study session.

For Aim 2, the efficacy of robot-assisted mobilization modes will be assessed by means of the longitudinal analysis of pre- and post-treatment measurements of MCP range of motion and pain intensity level, the flexion peak torque evaluation and the final administration of an ad-hoc satisfaction questionnaire.

For aim 3, the performance of WRL HX MCP will be studied by comparing the robotic MCP angle estimation with the measurements from a motion capture system.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • history of traumatic hand injury or post-traumatic hand surgery
  • hand size allowing to achieve proper exoskeleton fit
  • NRS pain score in the 1-5 range

Exclusion criteria

  • cognitive or linguistic ability insufficient to understand instructions
  • cardiac implanted electronic devices
  • open skin at the level of the patient-device interface
  • absence of contraindications for finger joints mobilisation
  • current or prior history of malignancy
  • pregnancy or breast feeding

Treatment and study plan

WRL HX MCP

Device

WRL HX MCP is a non CE marked class IIa medical device designed for clinical application in hand rehabilitation; it consists in a cable-driven robotic MCP orthosis providing flexion-extension of the metacarpo-phalangeal joint. WRL HX MCP features and a series-elastic actuators (SEA) architecture for compliant actuation of MCP flexion-extension and a self-aligning mechanism to absorb human/robot joint axes misplacement. Exoskeleton module is mounted on a dorsal hand support and connected to its electronic box through wires.

Primary outcomes

  1. Feasibility indicator: completion of study procedures

    Time frame: through study completion, an average of 1 year

    Percent of participants for whom study procedures were completed successfully

  2. Feasibility indicator: patient acceptability

    Time frame: After the robotic therapy session; the total expected time for the session is about 90 minutes.

    Clinician-generated questionnaire to investigate patients' impressions about the physical interaction with the robotic device

  3. Feasibility indicator: reliability evaluated through the number of device malfunctions

    Time frame: through study completion, an average of 1 year

    The physiotherapist is required to report any malfunctions occurring during the study in regard to the use of WRL HX MCP

Secondary outcomes

  1. Goniometric measure of MCP Active Range of Motion (AROM)

    Time frame: at baseline and immediately after the robotic therapy session.

    The physiotherapist measures the MCP joint angles in maximum active flexion and extension using a short-arm goniometer

  2. Goniometric measure of MCP Passive Range of Motion (PROM)

    Time frame: at baseline and immediately after the robotic therapy session

    The physiotherapist measures the MCP joint angles in maximum passive flexion and extension using a short-arm goniometer

  3. Robotic measure of MCP Active Range of Motion (AROM)

    Time frame: at baseline and immediately after the robotic therapy session

    MCP joint maximum active flexion and extension range of motion is registered while the device and human joint are coupled together, using WRL HX MCP set in a transparent mode as an evaluation tool, without any manual assistance.

  4. Robotic measure of MCP passive Range of Motion (PROM)

    Time frame: at baseline and immediately after the robotic therapy session

    MCP joint maximum passive flexion and extension range of motion is registered while the device and human joint are coupled together, using WRL HX MCP set in a transparent mode as an evaluation tool, with manual assistance from the therapist.

  5. Robotic estimation of MCP joint flexion peak torque

    Time frame: during robot-in-charge mobilization sequences

    MCP joint flexion peak torque is evaluated by the exoskeleton torque joint sensor during the robot-in-charge mobilization sequences

  6. Numeric Pain Rating Scale (NPRS)

    Time frame: at baseline and after each of the two series of joint mobilization exercises, lasting up to 30 minutes each.

    NPRS is an 11-point scale for patient self-reporting of pain, with 0 being "no pain" and 10 being "the worst pain imaginable"

  7. Safety evaluated through the number of adverse events

    Time frame: through study completion, an average of 1 year

    The physiotherapist is required to report any adverse events occurring during the study in regard to the use of WRL HX MCP

Sponsors and collaborators

Lead sponsor

Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro

Other

Collaborators

  • Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna

Registry information

Official study title

Hand Motor Rehabilitation Using a Wearable Robotic Device (WRL HX MCP): a Pilot Study

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Dec 13, 2021
Registry last updated
Mar 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.